DE602007010797D1 - Pharmazeutische zusammensetzungen mit rosuvastatin-calcium - Google Patents

Pharmazeutische zusammensetzungen mit rosuvastatin-calcium

Info

Publication number
DE602007010797D1
DE602007010797D1 DE602007010797T DE602007010797T DE602007010797D1 DE 602007010797 D1 DE602007010797 D1 DE 602007010797D1 DE 602007010797 T DE602007010797 T DE 602007010797T DE 602007010797 T DE602007010797 T DE 602007010797T DE 602007010797 D1 DE602007010797 D1 DE 602007010797D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
rosuvastatin calcium
rosuvastatin
calcium
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007010797T
Other languages
English (en)
Inventor
Maria Viragh
Iidiko Monostori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Nyrt
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of DE602007010797D1 publication Critical patent/DE602007010797D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602007010797T 2006-09-18 2007-09-11 Pharmazeutische zusammensetzungen mit rosuvastatin-calcium Active DE602007010797D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0600728A HU227610B1 (en) 2006-09-18 2006-09-18 Pharmaceutical compositions containing rosuvastatin potassium
PCT/HU2007/000082 WO2008035128A1 (en) 2006-09-18 2007-09-11 Pharmaceutical compositions containing rosuvastatin calcium

Publications (1)

Publication Number Publication Date
DE602007010797D1 true DE602007010797D1 (de) 2011-01-05

Family

ID=89987035

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007010797T Active DE602007010797D1 (de) 2006-09-18 2007-09-11 Pharmazeutische zusammensetzungen mit rosuvastatin-calcium

Country Status (24)

Country Link
US (1) US8221788B2 (de)
EP (1) EP2063868B1 (de)
JP (1) JP5534812B2 (de)
CN (1) CN101516349A (de)
AR (1) AR062874A1 (de)
AT (1) ATE489078T1 (de)
AU (1) AU2007298751B2 (de)
CA (1) CA2662919C (de)
CY (1) CY1114533T1 (de)
DE (1) DE602007010797D1 (de)
DK (1) DK2063868T3 (de)
EA (1) EA014451B1 (de)
ES (1) ES2357263T3 (de)
HR (1) HRP20110125T1 (de)
HU (1) HU227610B1 (de)
JO (1) JO2641B1 (de)
ME (1) ME01944B (de)
PL (1) PL2063868T3 (de)
PT (1) PT2063868E (de)
RS (1) RS51563B (de)
SI (1) SI2063868T1 (de)
TW (1) TWI454265B (de)
UA (1) UA97489C2 (de)
WO (1) WO2008035128A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
TR200800269A2 (tr) * 2008-01-15 2009-08-21 Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. Stabil farmasötik formülasyon ve hazırlama yöntemleri
KR101577083B1 (ko) 2008-01-28 2015-12-11 뷰티 펄 그룹 리미티드 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물
WO2009112870A1 (en) * 2008-03-11 2009-09-17 Belupo-Lijekovi I Kozmetika D.D. Pharmaceutical composition comprising rosuvastatin calcium and magnesium carbonate hydroxide pentahydrate as a stabilizer
EA024554B1 (ru) * 2008-06-27 2016-09-30 Крка, Товарна Здравил, Д.Д., Ново Место Твердая лекарственная форма, содержащая розувастатин, и способ ее получения
EP2138165A1 (de) 2008-06-27 2009-12-30 KRKA, tovarna zdravil, d.d., Novo mesto Pharmazeutische Zusammensetzung mit einem Statin
PL386051A1 (pl) * 2008-09-09 2010-03-15 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Stabilna doustna kompozycja farmaceutyczna zawierająca farmaceutycznie dopuszczalną sól kwsu [(E)-7-[4-(4-fluorofenylo)-6-izopropylo-2-[metylo(metylosulfonylo)amino]pirymidyn-5-ylo] (3R,5S)-3,5-dihydroksyhept-6-enowego
TR200904341A2 (tr) 2009-06-03 2010-12-21 Bi̇lgi̇ç Mahmut Rosuvastatin kalsiyum içeren kararlı farmasötik bileşimler.
EP2566465A2 (de) 2010-05-04 2013-03-13 Mahmut Bilgic Stabile rosuvastatinformulierungen
CN101972260B (zh) * 2010-11-24 2012-05-02 天津市汉康医药生物技术有限公司 一种瑞舒伐他汀钙口服药物组合物
CN103648485A (zh) * 2011-05-20 2014-03-19 阿斯利康(英国)有限公司 罗苏伐他汀钙的药物组合物
CN102860994B (zh) * 2011-07-04 2016-01-20 石药集团中奇制药技术（石家庄）有限公司 一种瑞舒伐他汀钙片及其制备方法
CN116768882A (zh) 2012-09-18 2023-09-19 奥斯拜客斯制药有限公司 化合物、及其药物组合物及治疗方法
US9550780B2 (en) 2012-09-18 2017-01-24 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
CN102908335B (zh) * 2012-11-19 2015-04-08 山东罗欣药业集团股份有限公司 一种瑞舒伐他汀钙组合物及其制备方法
CN103961354A (zh) * 2013-02-05 2014-08-06 深圳信立泰药业股份有限公司 一种稳定的瑞舒伐他汀钙药物组合物及其制备方法
RO129060B1 (ro) 2013-04-25 2014-11-28 Antibiotice S.A. Compoziţie farmaceutică stabilă cu rosuvastatină calcică amorfă
RU2547574C2 (ru) * 2013-07-09 2015-04-10 Общество с ограниченной ответственностью "Трейдсервис" Лекарственная форма гиполипидемического действия и способ ее изготовления
CN103494788B (zh) * 2013-10-10 2015-08-05 齐晓彤 瑞舒伐他汀钙片的药物组合物及其制备方法
EA032920B1 (ru) 2013-12-03 2019-08-30 Оспекс Фармасьютикалз, Инк. Способы получения соединений бензохинолина
BR112017009521A2 (pt) * 2014-11-11 2017-12-19 Shionogi & Co comprimido de múltiplas camadas que contém um fármaco instável à luz
CN104523650B (zh) * 2014-12-20 2017-04-12 山东新时代药业有限公司 一种含有瑞舒伐他汀钙的胶囊
CN114796209A (zh) 2015-03-06 2022-07-29 奥斯拜客斯制药有限公司 氘代丁苯那嗪或包含氘代丁苯那嗪的组合物
JP2016169198A (ja) * 2015-03-13 2016-09-23 大原薬品工業株式会社 ロスバスタチンカルシウムを含有する錠剤
JP6095176B2 (ja) * 2015-04-24 2017-03-15 大原薬品工業株式会社 ロスバスタチンカルシウムの光安定性が向上したフィルムコーティング錠剤
CN104840964B (zh) * 2015-05-07 2018-01-16 南京正大天晴制药有限公司 一种稳定的索氟布韦药物组合物及其制备方法
CN105168158B (zh) * 2015-08-18 2018-08-03 上海韬鸿化工科技有限公司 一种瑞舒伐他汀钙分散片及其制备方法
EP3243506A1 (de) 2016-05-09 2017-11-15 Adamed sp. z o.o. Pharmazeutische zusammensetzung
CN108245516B (zh) * 2017-11-09 2019-04-12 浙江京新药业股份有限公司 一种含瑞舒伐他汀钙的药物组合物及其制备方法
CN112274487A (zh) * 2019-07-25 2021-01-29 北京福元医药股份有限公司 一种瑞舒伐他汀钙药物制剂
CN115317455B (zh) * 2022-08-17 2023-08-22 新发药业有限公司 一种药片含量均匀、易于溶出的瑞舒伐他汀钙片及其制备方法
GB2622822A (en) 2022-09-28 2024-04-03 Novumgen Ltd A rapidly disintegrating tablet of rosuvastatin and its process of preparation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
SI20109A (sl) * 1998-12-16 2000-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Stabilna farmacevtska formulacija
US6569461B1 (en) 1999-03-08 2003-05-27 Merck & Co., Inc. Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors
DE60042565D1 (de) * 1999-07-20 2009-08-27 3M Innovative Properties Co Feuerlöschzusammensetzung
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
US20030031720A1 (en) 2000-02-24 2003-02-13 Tobias Laich Method for producing pharmaceutical dosage forms
GB0111077D0 (en) 2001-05-04 2001-06-27 Biochemie Gmbh Organic compounds
OA12777A (en) * 2002-02-14 2006-07-06 Ranbaxy Lab Ltd Formulations of atorvastatin stabilized with alkali metal additions.
GB0217306D0 (en) * 2002-07-25 2002-09-04 Novartis Ag Compositions comprising organic compounds
SI21400A (sl) * 2003-02-12 2004-08-31 LEK farmacevtska družba d.d. Stabilna farmacevtska oblika z inhibitorjem HMG-CoA reduktaze
AU2003269478A1 (en) * 2003-08-27 2005-03-16 Hetero Drugs Limited A novel process for amorphous rosuvastatin calcium
US20080131503A1 (en) * 2005-02-10 2008-06-05 Per Holm Stable Pharmaceutical Composition Comprising a Fixed Dose Combination of Fenofibrate and an Hmg-Coa Reductase Inhibitor
EP1905424A3 (de) * 2006-02-02 2008-04-30 Ranbaxy Laboratories Limited Verfahren zur Herstellung einer pharmazeutischen Zusammensetzung, die stabilisierte Statin-Partikel enthält

Also Published As

Publication number Publication date
CN101516349A (zh) 2009-08-26
HUP0600728A2 (en) 2008-06-30
TW200829246A (en) 2008-07-16
PT2063868E (pt) 2010-12-23
HU227610B1 (en) 2011-09-28
CY1114533T1 (el) 2016-10-05
JP2010503723A (ja) 2010-02-04
AU2007298751A1 (en) 2008-03-27
EA200970291A1 (ru) 2009-06-30
AR062874A1 (es) 2008-12-10
TWI454265B (zh) 2014-10-01
ES2357263T3 (es) 2011-04-20
JO2641B1 (en) 2012-06-17
UA97489C2 (ru) 2012-02-27
CA2662919A1 (en) 2008-03-27
HU0600728D0 (en) 2006-11-28
CA2662919C (en) 2013-04-30
EP2063868B1 (de) 2010-11-24
US20090297599A1 (en) 2009-12-03
EP2063868A1 (de) 2009-06-03
ME01944B (me) 2011-08-31
SI2063868T1 (sl) 2011-03-31
US8221788B2 (en) 2012-07-17
HRP20110125T1 (hr) 2011-03-31
EA014451B1 (ru) 2010-12-30
DK2063868T3 (da) 2011-02-07
AU2007298751B2 (en) 2013-05-02
WO2008035128A1 (en) 2008-03-27
ATE489078T1 (de) 2010-12-15
PL2063868T3 (pl) 2011-05-31
RS51563B (en) 2011-08-31
JP5534812B2 (ja) 2014-07-02

Similar Documents

Publication Publication Date Title
DE602007010797D1 (de) Pharmazeutische zusammensetzungen mit rosuvastatin-calcium
LTC2140867I2 (lt) Farmacinė kompozicija
ATE493119T1 (de) Pharmazeutische zusammensetzung
ATE532788T1 (de) Pharmazeutische verbindungen
BRPI0715712A2 (pt) Composição farmacêutica
DK2399579T3 (da) Farmaceutiske doseringsformer
ATE531358T1 (de) Selbsterhaltende wässrige pharmazeutische zusammensetzungen
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
BRPI0719393A2 (pt) Composição farmacêutica
ATE517619T1 (de) Stabilisierte pharmazeutische zusammensetzung mit fesoterodin
BRPI0616703A2 (pt) forma de dosagem farmacêutica
BRPI0721651A2 (pt) Composição farmacêutica
DK1986650T3 (da) Manipulationssikre doserignsformer
RU2398586C3 (ru) Фармацевтическая композиция
DK1984009T3 (da) Farmaceutiske sammensætninger med forbedret stabilitet
BRPI0810928A2 (pt) "composição farmacêutica"
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0720234A2 (pt) Composição farmacêutica
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung
ATE480227T1 (de) Pharmazeutische zusammensetzungen mit quetiapinfumarat
BRPI0822782A2 (pt) composição farmacêutica que compreende rosuvastatina
BRPI0814658A2 (pt) Composição farmacêutica líquida estável
DE602006017975D1 (de) Feste pharmazeutische zusammensetzung mit telithromycin
DE602005016105D1 (de) Pharmazeutische zusammensetzungen mit zd6474
BRPI0820839A2 (pt) Composição farmacêutica

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: DERZEIT KEIN VERTRETER BESTELLT